Abstract:Objective To study the changes in levels of interleukin (IL)-6, IL-10, tumor necrosis factor-alpha (TNF-α), and alkaline phosphatase (ALP) in the gingival crevicular fluid (GCF) of patients with severe chronic periodontitis before and after nonsurgical periodontal therapy and to explore the relationship among the levels of these four biomarkers in GCF, their periodontal status and their clinical significance to evaluate the effect of nonsurgical periodontal therapy and periodontitis activity. Methods In total, 30 patients with severe chronic periodontitis were enrolled in a 1-year longitudinal pilot study (Chinese Clinical Trial Registry: ChiCTR-OCH-13004679). At baseline and 1, 3, 6, and 12 months after nonsurgical therapy, the periodontal clinical indicators plaque index (PLI), probing depth (PD), clinical attachment loss (CAL), sulcus bleeding index (SBI) were recorded. Filter paper strips were used to collect two deep-pocket (probing depth ≥ 6 mm) and two shallow-pocket (probing depth ≤ 4 mm) periodontal sites for each patient and weighed. The levels of interleukin IL-6, IL-10, TNF-α, and ALP in GCF were assessed using enzyme-linked immunosorbent assay. Meanwhile, 30 healthy sites of 15 subjects with healthy periodontium were used as the baseline controls for patients with severe chronic periodontitis. Results At the baseline, the TNF-α, ALP and IL-6 levels in GCF of the disease sites of patients with periodontitis were significantly higher than those in healthy periodontal sites of the control group (P < 0.001), and the levels of IL-10 were significantly lower than those in the control group (P < 0.001). In patients with severe chronic periodontitis, the levels of TNF-α, ALP and IL-6 in GCF at deep-pocket sites were significantly higher than those at shallow-pocket sites (P <0.001), and the IL-10 levels were significantly lower than those at shallow-pocket sites (P < 0.001). 1, 3, 6, and 12 months after nonsurgical treatment, the levels of TNF-α and ALP in GCF at the shallow- and deep-pocket sites in patients with chronic periodontitis significantly decreased, the level of IL-10 significantly increased (P < 0.005), and the level of IL-6 in GCF at the deep-pocket sites significantly decreased (P < 0.005). However, there was no significant difference in IL-6 level at shallow-pocket sites (P > 0.05). 1, 3, 6, and 12 months after nonsurgical treatment, the periodontal clinical indicators were improved compared with the baseline. In addition, there was a significant correlation between the levels of these four biomarkers and the periodontal clinical parameters (P < 0.05). During the two follow-up visits after nonsurgical periodontal therapy, the sites with more than 2-mm increase in attachment loss had significant differences in the levels of the four biomarkers in the GCF compared with the previous visit time (P < 0.005). Conclusion The detection of the levels of these four biomarkers in GCF has strong clinical significance for assessing the severity of periodontitis and the efficacy of nonsurgical periodontal therapy. Increased levels of TNF-α, ALP, and IL-6 and decreased IL-10 levels in GCF may indicate periodontitis progression at this site.

Longitudinal study of volatile fatty acids in the gingival crevicular fluid of patients with periodontitis before and after nonsurgical therapy.

Effect of non-surgical periodontal treatment on short chain fatty acid levels in gingival crevicular fluid of patients with generalized aggressive periodontitis

[Analysis of Volatile Fatty Acids in Gingival Crevicular Fluid of Patients with Chronic Periodontitis].

[Analysis of Short Chain Fatty Acids in Gingival Crevicular Fluid of Patients with Aggressive Periodontitis].

Relationship between volatile fatty acids and Porphyromonas gingivalis and Treponema denticola in gingival crevicular fluids of patients with aggressive periodontitis]

Relationship between volatile fatty acids in gingival crevicular fluid and Porphyromonas gingivalis

Cytokine Levels in Plasma and Gingival Crevicular Fluid in Chronic Periodontitis.

Changes and clinical significance of four biomarkers in gingival crevicular fluid after nonsurgical periodontal therapy

[Relationship Between Short-Chain Fatty Acids in the Gingival Crevicular Fluid and Periodontitis of Stage Ⅲ or Ⅳ].

Gingival Crevicular Fluid Biomarkers During Periodontitis Progression and After Periodontal Treatment

Short-chain carboxylic acid concentration in human gingival crevicular fluid

NonsurgicaI Treatment on MMP-8 and TIMP-1 LeveIs in GingivaI CrevicuIar FIuid from Advanced Chronic Periodontitis Patients

Effect of nonsurgical periodontal therapy on C-reactive protein levels in gingival crevicular fluid in severe chronic periodontitis

Relationship between salivary occult blood and level of volatile sulphur compounds in oral cavity

The relationship of gingival crevicular fluid short chain carboxylic acid concentration to gingival inflammation

Effect of non-surgical periodontal therapy on putative periodontal pathogens in saliva and gingival crevicular fluids in patients with aggressive periodontitis

The Clinical Observations and the Measurement of Gingival Crevicular Fluid Volume During the Experimental Gingivitis

[Clinical and Putative Periodontal Pathogens' Features of Different Sites with Probing Depth Reduction after Non-Surgical Periodontal Treatment of Patients with Aggressive Periodontitis].

Influence of supragingival biofilm control and smoking habit on Interleukin-1β concentration

Preliminary study on relations between GCF and periodontal clinical index under two sampling method

Change of crevicular fluid interleukin-10 level in pre-and after-periodontal therapy in chronic periodontitis